NDC 59368-402 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-402
- Package NDCs from labels
- 59368-402-01
- Manufacturer
- Praxis, LLC
- Effective date
- 2023-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen - Praxis, LLC | Praxis, LLC | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | Meijer Distribution, Inc. | 3e3a5366-535d-45fb-81af-c7d98ac20b11 | 2026-05-15 | Warnings | WK2XYI10QM |
| HEMORRHOIDAL WITH LIDOCAINE | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY, INC | 4d870c68-9e72-464e-b0b8-900d0d661e43 | 2026-05-14 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | ST. MARY'S MEDICAL PARK PHARMACY | 88dda062-2b9c-3632-e053-2a95a90a1431 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | bdc3f482-6fba-4420-9118-0f5cb7744e97 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals, Inc. | 72ec2491-924d-460f-9510-62d624d54b59 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | 60c731c6-4dc4-490a-8469-0b7e58e563a1 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | 13fd4401-1821-4f2b-a44e-96aa2fa75b5c | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | 25d9f5fc-4d95-4018-add8-ba696b6079b2 | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Systane Pro PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a12baf3d-f22b-4c9f-a4c8-4e0d09f6d6f1 | 2026-05-12 | Warnings | 6DC9Q167V3 |
| Motrin Infants | IBUPROFEN | Kenvue Brands LLC | c57f6ded-c0bd-45ae-823a-4c02ce334d98 | 2026-05-12 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | QPharma Inc | fd8b82a7-96fe-8bf5-e053-6394a90a3935 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen minis | IBUPROFEN | CVS Pharmacy | a6fc144a-6826-4bf7-8efb-8cdb896387f1 | 2026-05-12 | Warnings | WK2XYI10QM |
| Market Basket Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Demoulas Super Markets, Inc. | e15439c7-0e3c-7752-e053-2995a90a1a40 | 2026-05-11 | Warnings | XF417D3PSL |
| Meijer Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Meijer Distribution Inc | 7305972b-aa0f-4daa-e053-2991aa0adfd7 | 2026-05-11 | Warnings | XF417D3PSL |
| Good Sense Infants Ibuprofen | IBUPROFEN | L. Perrigo Company | 3d2fa7ad-1574-4c79-959d-3ee284468a99 | 2026-05-11 | Warnings | WK2XYI10QM |
| Childrens Ibuprofen Oral Suspension Dye free | IBUPROFEN | AptaPharma Inc. | bb995c57-a2cc-4bc7-9c7d-f885c425be64 | 2026-05-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | NuCare Pharmaceuticals,Inc. | 05ce8e8e-0b25-061e-e063-6394a90a2e92 | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| ibuprofen infants | IBUPROFEN | H E B | e353bc69-c03e-4bae-a357-f7f3fab91695 | 2026-05-07 | Warnings | WK2XYI10QM |
| Sterile Water | WATER | Hospira, Inc. | 3a6422e1-feee-4095-8883-2b0837039e6e | 2026-05-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, POTASSIUM SORBATE, RESORCINUM, SALICYLICUM ACIDUM, | Energique, Inc. | 2831d28e-9cf1-4a72-9c6c-bb014d059558 | 2026-05-06 | Warnings | PDC6A3C0OX 506T60A25R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.